Frontal fibrosing alopecia: the fastest-growing scarring alopecia globally — what it is, why it's increasing, and the sunscreen hypothesis the experts are still debating.
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
0:00
|
6:45
From Root to Ritual by Laritelle Organic.
In brief: Frontal fibrosing alopecia (FFA) is a progressive scarring alopecia that has increased steadily in prevalence since its first clinical description in 1994 — now the most commonly encountered scarring alopecia in postmenopausal women globally. It presents as progressive frontotemporal hairline recession with a characteristic pale band of skin, eyebrow and eyelash loss, and facial papules....
Read the full article: https://laritelleorganic.com/blogs/from-root-to-ritual/frontal-fibrosing-alopecia-the-fastest-growing-scarring-alopecia-globally-what-it-is-why-its-increasing-and-the-sunscreen-hypothesis-the-experts-are-still-debating
SPEAKER_00
In brief, frontal fibrosing alopecia is a progressive scarring alopecia that has increased steadily in prevalence since its first clinical description in 1994, now the most commonly encountered scarring alopecia in postmenopausal women globally. It presents as progressive frontotemporal hairline recession with a characteristic pale band of skin, eyebrow and eyelash loss, and facial papules. The SOFIA 2024 International Consensus Statement, 69 hair experts from six continents, published in GDV on July 23, 2025, provides the most authoritative current guidance. A Spanish expert panel, January 2025, recommends avoiding organic UV filters and benzyl salicylate in cosmetics for FFA patients. Treatment stabilizes, it does not reverse established scarring. The CCCA article covered the most common scarring alopecia in black women. This article covers the most common scarring alopecia in postmenopausal women of all backgrounds, and the one whose prevalence is increasing most rapidly worldwide. Frontal fibrosing alopecia is a scarring alopecia, the prevalence of which is increasing worldwide since its first description in 1994. It is an inflammatory scarring hair loss that commonly affects postmenopausal women and presents as frontal hairline recession, facial papules, loss of eyebrows, and facial hyperpigmentation. The rate of increase is striking. FFA went from a rarely documented condition to the most commonly encountered scarring alopecia in dermatology clinics across Europe and North America within three decades. As the incidence of frontal fibrosing alopecia continues to rise, there is a need for an optimal treatment algorithm for FFA. That is the opening line of the SOFIA 2024 consensus paper. 69 experts from six continents convene to address exactly this need. What is frontal fibrosing alopecia? And how is it diagnosed? FFA is a form of lichen planopolaris, a lymphocytic lichanoid inflammatory condition that causes immune-mediated destruction of hair follicle stem cells in the bulge region, followed by replacement of follicle tissue with fibrous scar. Once follicles in an area are replaced by fibrous tissue, the loss in that area is permanent. The classic clinical presentation has four features progressive frontotemporal hairline recession. The most visible sign, the hairline recedes in a band across the front and temples. Unlike AGA recession in women, which thins the crown while preserving the frontal hairline, FFA recession is at the very edge of the hairline itself. A characteristic pale band of skin immediately in front of the receding hairline, the lonely hair sign, where isolated hairs remain ahead of the main hairline, is a highly specific clinical finding for FFA. The recession is typically bilateral and symmetric, often with the frontal hairline and temples receding simultaneously rather than sequentially. Eyebrow and eyelash loss. Eyebrow loss occurs in approximately 50-80% of FFA patients, often preceding or concurrent with hairline recession and sometimes preceding it by years. The eyebrow loss follows the same inflammatory scarring mechanism as scalp loss, lymphocytic infiltration at the follicle bulge, followed by permanent fibrosis. Eyelash loss is less common, but occurs. Eyebrow loss alone, particularly in a postmenopausal woman, warrants dermatological evaluation for FFA even before hairline recession becomes visible. Facial papules and body hair loss, approximately 30 to 50% of FFA patients, develop small flesh-colored papules on the face, particularly the cheeks and temples. These represent follicular inflammation in facial vellus hair follicles, the same process operating in miniaturized facial follicles as in the scalp. Body hair loss, axillary, pubic, leg hair, also occurs in a proportion of patients, reflecting the systemic nature of the inflammatory process, rather than a purely localized scalp condition. Trichoscopy, the diagnostic tool FFA diagnosis, should rely on clinical and trichoscopic criteria. Trichoscopy is highly valuable, not only for initial diagnosis, recommended at the first consultation, but also for monitoring treatment response. Spanish Expert Consensus, January 2025. On trichoscopy, FFA shows a characteristic pattern, perifollicular erythema and scaling at the hairline, absent follicular openings in scarred areas, isolated hairs ahead of the main hairline, and the pale parapollicular halo that reflects the inflammatory infiltrate sew, rounding affected follicles. Scalp biopsy confirms the diagnosis in atypical presentations, showing liconoid interface inflammation at the follicle bulge and fibrous tracts replacing follicle tissue. Why is FFA increasing? And what is the sunscreen hypothesis? The most controversial and most discussed aspect of FFA's rising prevalence is the environmental trigger hypothesis. Specifically, whether sunscreen use and certain cosmetic ingredients are contributing to disease onset in genetically predisposed individuals. Environmental triggers such as implicated cosmetic products, sunblock, personal hair care products, and moisturizers introduce complexity to understanding FFA's pathogenesis, JAD, April 2026. The epidemiological observation? Multiple studies have found that FFA patients report significantly higher rates of regular sunscreen use than age-matched controls without FFA. A 2022 Spanish cross-sectional study of 101 FFA patients and 40 controls found significantly greater sunscreen use in the FFA group. A 2022 JAAD systematic review and meta-analysis confirmed this association across pooled studies. The honest complication there is insufficient evidence to establish a direct causal relationship between sunscreen and FFA. The higher usage may simply reflect a new behavior adopted because of the alopecia, or may reflect higher socioeconomic status. Moreover, the increasing number of FFA cases in black skinned patients, among whom rates of sunscreen use are GE.